Patent details
EP3681483 Title: PROCESS FOR LYOPHILIZED PHARMACEUTICAL FORMULATION OF A THERAPEUTIC PROTEIN
Basic Information
- Publication number:
- EP3681483
- PCT Application Number:
- US2018050305
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP187791678
- PCT Publication Number:
- WO2019055357
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PROCESS FOR LYOPHILIZED PHARMACEUTICAL FORMULATION OF A THERAPEUTIC PROTEIN
- French Title of Invention:
- PROCÉDÉ DE FORMULATION PHARMACEUTIQUE LYOPHILISÉE D'UNE PROTÉINE THÉRAPEUTIQUE
- German Title of Invention:
- VERFAHREN ZUR LYOPHILISIERTEN PHARMAZEUTISCHEN FORMULIERUNG EINES THERAPEUTISCHEN PROTEINS
- SPC Number:
Dates
- Filing date:
- 10/09/2018
- Grant date:
- 18/05/2022
- EP Publication Date:
- 22/07/2020
- PCT Publication Date:
- 21/03/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/05/2022
- EP B1 Publication Date:
- 18/05/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 10/09/2038
- Renunciation date:
- Revocation date:
- 28/08/2025
- Annulment date:
Owner
- From:
- 11/05/2022
- Name:
- Amgen Inc.
- Address:
- One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)
Agent
- Name:
- ARONOVA S.A.
- From:
- 18/08/2022
- Address:
- PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
- Name:
- TALLEY, Clea
- Address:
- United States (US)
Priority
- Priority Number:
- 201762559420 P
- Priority Date:
- 15/09/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/19; A61K 47/10; A61K 47/26; A61K 47/18; A61K 38/19;
Publication
Bulletin
- Bulletin Heading:
- VRV
- Bulletin edition number:
- 2025/12
- Publication date:
- 07/11/2025
- Description:
- Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates
European Patent Bulletin
1
- Issue number:
- 202220
- Publication date:
- 18/05/2022
- Description:
- Grant (B1)
2
- Issue number:
- 202541
- Publication date:
- 08/10/2025
- Description:
- Revocation of the European patent
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 20/08/2025
- Last Annual Fee Paid Number:
- 8
- Last Annual Fee Paid Amount:
- 99 Euro
- Payer:
- ANAQUA SERVICES (ANC. SGA2)
| Filing date | Document type | Number of pages |
|---|---|---|
| 18/08/2022 | Power Of Attorney | 1 |
| 19/08/2022 | Outgoing Correspondence | 1 |